Skip to main content
Biochemical Journal logoLink to Biochemical Journal
. 1987 Aug 15;246(1):149–156. doi: 10.1042/bj2460149

Complement factor H-binding protein of Raji cells and tonsil B lymphocytes.

A Erdei 1, R B Sim 1
PMCID: PMC1148251  PMID: 2960319

Abstract

Several reports have indicated that Factor H has specific effects on certain cell populations, suggesting that Factor H receptors may exist. Lambris & Ross [(1982) J. Exp. Med. 155, 1400-1411] purified a protein from Raji B-lymphoblastoid cell culture supernatants, using Factor H-Sepharose affinity chromatography. This species appeared to consist of two disulphide-linked components each of Mr 50,000, with an additional 50,000-Mr chain attached non-covalently. The existence of cell-surface Factor H-binding proteins has now been re-investigated with 125I surface-labelled Raji and tonsil B cells. Non-ionic-detergent extracts of the cells, in 0.1% Nonidet P40/10 mM-sodium phosphate buffer, pH 7.4, were incubated with Factor H-Sepharose in the presence of proteinase inhibitors. After the beads had been washed, bound components were eluted with 50 mM-NaCl. A single radioactive species was eluted from the resin, which migrates identically with Factor H (apparent Mr 170,000) in SDS/polyacrylamide-gel electrophoresis under reducing and non-reducing conditions. Biosynthetic radiolabelling studies confirmed that this species was synthesized by Raji cells. Examination of culture supernatants from biosynthetically radiolabelled Raji cells showed again the presence of a single soluble species that bound to Factor H-Sepharose, but this species was of lower Mr (approx. 105,000) than the membrane-derived protein. The soluble form may be produced by proteolysis of the membrane form, or may be of separate origin. The similarity in size of the cell-surface protein to Factor H was initially confusing, but it is distinct from cell-surface Factor H on the basis of three criteria: (1) it is not recognized by anti-(Factor H) monoclonal antibodies MRC OX23 and MRC OX24, nor by polyclonal F(ab')2 anti-(Factor H); (2) it does not bind to Zn2+-chelate resin, whereas Factor H does; (3) cell-surface Factor H present on U937 cells does not bind to Factor H-Sepharose.

Full text

PDF
149

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Fearon D. T. Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane. Proc Natl Acad Sci U S A. 1979 Nov;76(11):5867–5871. doi: 10.1073/pnas.76.11.5867. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Hartung H. P., Hadding U., Bitter-Suermann D., Gemsa D. Release of prostaglandin E and thromboxane from macrophages by stimulation with factor H. Clin Exp Immunol. 1984 May;56(2):453–458. [PMC free article] [PubMed] [Google Scholar]
  3. Ishizaka K. Regulation of IgE synthesis. Annu Rev Immunol. 1984;2:159–182. doi: 10.1146/annurev.iy.02.040184.001111. [DOI] [PubMed] [Google Scholar]
  4. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  5. Lambris J. D., Dobson N. J., Ross G. D. Release of endogenous C3b inactivator from lymphocytes in response to triggering membrane receptors for beta 1H globulin. J Exp Med. 1980 Dec 1;152(6):1625–1644. doi: 10.1084/jem.152.6.1625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Lambris J. D., Ross G. D. Characterization of the lymphocyte membrane receptor for factor H (beta 1H-globulin) with an antibody to anti-factor H idiotype. J Exp Med. 1982 May 1;155(5):1400–1411. doi: 10.1084/jem.155.5.1400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Malhotra V., Sim R. B. Expression of complement factor H on the cell surface of the human monocytic cell line U937. Eur J Immunol. 1985 Sep;15(9):935–941. doi: 10.1002/eji.1830150913. [DOI] [PubMed] [Google Scholar]
  8. Markwell M. A., Fox C. F. Surface-specific iodination of membrane proteins of viruses and eucaryotic cells using 1,3,4,6-tetrachloro-3alpha,6alpha-diphenylglycoluril. Biochemistry. 1978 Oct 31;17(22):4807–4817. doi: 10.1021/bi00615a031. [DOI] [PubMed] [Google Scholar]
  9. Micklem K. J., Sim R. B., Sim E. Analysis of C3-receptor activity on human B-lymphocytes and isolation of the complement receptor type 2 (CR2). Biochem J. 1984 Nov 15;224(1):75–86. doi: 10.1042/bj2240075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Micklem K., Sim E., Sim R. B. The generation of active fragments of complement receptor type 2 by trypsin digestion. FEBS Lett. 1985 Sep 23;189(2):195–201. doi: 10.1016/0014-5793(85)81022-x. [DOI] [PubMed] [Google Scholar]
  11. Neauport-Sautes C., Rabourdin-Combe C., Fridman W. H. T-cell hybrids bear Fcgamma receptors and secrete suppressor immunoglobulin binding factor. Nature. 1979 Feb 22;277(5698):656–659. doi: 10.1038/277656a0. [DOI] [PubMed] [Google Scholar]
  12. Pangburn M. K., Müller-Eberhard H. J. Complement C3 convertase: cell surface restriction of beta1H control and generation of restriction on neuraminidase-treated cells. Proc Natl Acad Sci U S A. 1978 May;75(5):2416–2420. doi: 10.1073/pnas.75.5.2416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ripoche J., Al Salihi A., Rousseaux J., Fontaine M. Isolation of two molecular populations of human complement factor H by hydrophobic affinity chromatography. Biochem J. 1984 Jul 1;221(1):89–96. doi: 10.1042/bj2210089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ripoche J., Day A. J., Willis A. C., Belt K. T., Campbell R. D., Sim R. B. Partial characterization of human complement factor H by protein and cDNA sequencing: homology with other complement and non-complement proteins. Biosci Rep. 1986 Jan;6(1):65–72. doi: 10.1007/BF01145180. [DOI] [PubMed] [Google Scholar]
  15. Schopf R. E., Hammann K. P., Scheiner O., Lemmel E. M., Dierich M. P. Activation of human monocytes by both human beta 1H and C3b. Immunology. 1982 Jun;46(2):307–312. [PMC free article] [PubMed] [Google Scholar]
  16. Seya T., Turner J. R., Atkinson J. P. Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b. J Exp Med. 1986 Apr 1;163(4):837–855. doi: 10.1084/jem.163.4.837. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Sim E., Palmer M. S., Puklavec M., Sim R. B. Monoclonal antibodies against the complement control protein factor H (beta 1 H). Biosci Rep. 1983 Dec;3(12):1119–1131. doi: 10.1007/BF01120205. [DOI] [PubMed] [Google Scholar]
  18. Sim R. B., DiScipio R. G. Purification and structural studies on the complement-system control protein beta 1H (Factor H). Biochem J. 1982 Aug 1;205(2):285–293. doi: 10.1042/bj2050285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Sim R. B., Malhotra V., Ripoche J., Day A. J., Micklem K. J., Sim E. Complement receptors and related complement control proteins. Biochem Soc Symp. 1986;51:83–96. [PubMed] [Google Scholar]
  20. Sunderland C. A., McMaster W. R., Williams A. F. Purification with monoclonal antibody of a predominant leukocyte-common antigen and glycoprotein from rat thymocytes. Eur J Immunol. 1979 Feb;9(2):155–159. doi: 10.1002/eji.1830090212. [DOI] [PubMed] [Google Scholar]
  21. Tsokos G. C., Inghirami G., Tsoukas C. D., Balow J. E., Lambris J. D. Regulation of immunoglobulin secretion by factor H of human complement. Immunology. 1985 Jul;55(3):419–426. [PMC free article] [PubMed] [Google Scholar]
  22. Whaley K., Ruddy S. Modulation of C3b hemolytic activity by a plasma protein distinct from C3b inactivator. Science. 1976 Sep 10;193(4257):1011–1013. doi: 10.1126/science.948757. [DOI] [PubMed] [Google Scholar]
  23. Yoon S. H., Fearon D. T. Characterization of a soluble form of the C3b/C4b receptor (CR1) in human plasma. J Immunol. 1985 May;134(5):3332–3338. [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES